Sofinnova Partners SAS

Holdings History for Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value (QNCX)

Symbol: QNCX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 par value
Latest Disclosed Shares Owned: 1,197,711 shares
Security Ownership %: 2.7%

Sofinnova Capital VIII ownership in Quince Therapeutics, Inc. Common Stock, par value $0.0001 par value (QNCX)

30 Apr 2025 - Sofinnova Capital VIII has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,197,711 shares of Quince Therapeutics, Inc. Common Stock, par value $0.0001 par value (QNCX). This represents 2.7% ownership of the company. In their previous filing dated 14 Feb 2025, Sofinnova Partners SAS had reported owning 2,397,711 shares, indicating a decrease of +50%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Sofinnova Capital VIII	2.7%	-54%	$1,185,734	1,197,711	-1,200,000	-50%	$0.99	13G/A	31 Mar 2025	30 Apr 2025, 16:06
Sofinnova Capital VIII	5.4%		$2,373,734	2,397,711			$0.99	13G	31 Dec 2024	14 Feb 2025, 16:29